Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide

Circulation. 2002 Aug 27;106(9):1127-32. doi: 10.1161/01.cir.0000030182.35880.3e.

Abstract

Background: We reported that HDL loses its antiinflammatory properties during acute influenza A infection in mice, and we hypothesized that these changes might be associated with increased trafficking of macrophages into the artery wall. The present study tested this hypothesis.

Methods and results: D-4F, an apolipoprotein A-I mimetic peptide, or vehicle in which it was dissolved (PBS) was administered daily to LDL receptor-null mice after a Western diet and after influenza infection. D-4F treatment increased plasma HDL cholesterol and paraoxonase activity compared with PBS and inhibited increases in LDL cholesterol and peak levels of interleukin-6 after infection. Lung viral titers were reduced by 50% in mice receiving D-4F. Injection of female mice with male macrophages, which were detected with real-time polymerase chain reaction to measure the male Sry gene, revealed a marked increase in macrophage traffic into the aortic arch and innominate arteries after infection that was prevented by administration of D-4F.

Conclusions: We conclude that loss of antiinflammatory properties of HDL after influenza infection in mice is associated with increased arterial macrophage traffic that can be prevented by administration of D-4F.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Aorta, Thoracic / pathology
  • Apolipoprotein A-I / analogs & derivatives*
  • Apolipoprotein A-I / pharmacology*
  • Aryldialkylphosphatase
  • Behavior, Animal / drug effects
  • Body Temperature / drug effects
  • Brachiocephalic Trunk / pathology
  • Cell Movement / drug effects*
  • Cell Movement / immunology
  • Cells, Cultured
  • Diet, Atherogenic
  • Esterases / metabolism
  • Female
  • Genes, sry / genetics
  • In Vitro Techniques
  • Interleukin-6 / blood
  • Interleukin-6 / metabolism
  • Lipoproteins, HDL / blood
  • Lipoproteins, HDL / physiology
  • Lipoproteins, LDL / blood
  • Macrophages, Peritoneal / drug effects*
  • Macrophages, Peritoneal / immunology
  • Macrophages, Peritoneal / transplantation
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Monocytes / drug effects
  • Monocytes / immunology
  • Orthomyxoviridae Infections / drug therapy*
  • Orthomyxoviridae Infections / pathology
  • Orthomyxoviridae Infections / physiopathology
  • Peptides / pharmacology*
  • Pneumonia / drug therapy
  • Pneumonia / metabolism
  • Pneumonia / pathology
  • Receptors, LDL / deficiency
  • Receptors, LDL / genetics
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology
  • Virus Replication / drug effects

Substances

  • Apolipoprotein A-I
  • D-4F peptide
  • Interleukin-6
  • Lipoproteins, HDL
  • Lipoproteins, LDL
  • Peptides
  • Receptors, LDL
  • Esterases
  • Aryldialkylphosphatase